Cinpanemab
Cinpanemab (BIIB054) is a human-derived monoclonal antibody that binds to α-synuclein. Cinpanemab can be used for the research of Parkinson's disease[1][2].
Product Specifications
CAS Number
2094516-02-4
Product Name Alternative
BIIB054; Anti-Alpha-synuclein Reference Antibody (cinpanemab)
UNSPSC
12352203
Target
α-synuclein
Type
Inhibitory Antibodies
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cinpanemab.html
Purity
99.0
Solubility
H2O
Smiles
[Cinpanemab]
Molecular Weight
(146.98 kDa)
References & Citations
[1]Lang AE, et, al. Trial of Cinpanemab in Early Parkinson's Disease. N Engl J Med. 2022 Aug 4;387 (5) :408-420. |[2]Teng JS, et, al. Immunotherapies for Parkinson's Disease: Progression of Clinical Development. CNS Neurol Disord Drug Targets. 2021;20 (9) :802-813.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Isoform
α-synuclein
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS268240-04 10x 96 Well
Chicken lipoprotein lipase (LPL) ELISA Kit
Sign In for Pricing
View Details 
orb1946943-01 48 Tests
Rat V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) ELISA Kit
Sign In for Pricing
View Details orb1946943-02 96 Tests
Rat V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) ELISA Kit
Sign In for Pricing
View Details